FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lotronex (alosetron hydrochloride) submitted by Legacy Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• LOTRONEX (alosetron hydrochloride)

Snippet

SUPPL AP for LOTRONEX (ALOSETRON HYDROCHLORIDE)